News and Events
PathoQuest Appoints Eric Cazergue as Chief Financial Officer
PathoQuest Appoints Eric Cazergue as Chief Financial Officer PARIS, FRANCE — April 06, 2021 – PathoQuest, a pioneer of Next Generation Sequencing (NGS)-based testing solutions for the quality control of biologics, today announced the appointment of Eric Cazergue as...
PathoQuest Appoints Colette Côté as Chief Portfolio Officer and General Manager of the Company’s U.S. Subsidiary
PathoQuest Appoints Colette Côté as Chief Portfolio Officer and General Manager of the Company’s U.S. Subsidiary WAYNE, PA, and PARIS, FRANCE – March 18, 2021 – PathoQuest, a pioneer in the development and application of novel Next Generation Sequencing (NGS)-based...
PathoQuest Appoints Guillaume Deplaine, Ph.D., as Head of Operations
PathoQuest Appoints Guillaume Deplaine, Ph.D., as Head of Operations Dr. Guillaume Deplaine has 10 years of experience in the Biotechnology industry. Prior to joining PathoQuest, Dr. Deplaine was the Quality Control and Analytical Development Head at CELLforCURE a...
Contact us
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
Sign up for our latest news
Follow Us
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
Sign up for our latest news
Follow Us
How can PathoQuest help?
